4 September, 2021 by The TZ Newswire Staff Comments Off on Rolling Stone ‘Horse Dewormer’ Hit-Piece Debunked After Hospital Says No Ivermectin Overdoses
Rolling Stone ‘Horse Dewormer’ Hit-Piece Debunked After Hospital Says No Ivermectin Overdoses
Rolling Stone ‘Horse Dewormer’ Hit-Piece Debunked After Hospital Says No Ivermectin Overdoses
After Joe Rogan announced that he’d kicked Covid in just a few days using a cocktail of drugs, including Ivermectin – an anti-parasitic prescribed for humans for over 35 years, with over 4 billion doses administered (and most recently as a Covid-19 treatment), the left quickly started mocking Rogan for having taken a ‘hor
4 September, 2021 by The TZ Newswire Staff Comments Off on 3 Tech Hardware Stocks to Buy After Earnings
3 Tech Hardware Stocks to Buy After Earnings
A new tech hardware upgrade cycle is under way, and with the pandemic propelling digital change like never before, this strong demand phase for devices and tech infrastructure has no end in sight. Companies that cater to this market indicated as much during earnings season.
Three such companies that look like great buys — for the rest of 2021 and for the decade ahead — are Applied Materials (NASDAQ: AMAT), Arista Networks (NYSE: ANET), and Nvidia (NASDAQ: NVDA).
4 September, 2021 by The TZ Newswire Staff Comments Off on 3 Tech Hardware Stocks to Buy After Earnings
3 Tech Hardware Stocks to Buy After Earnings
A new tech hardware upgrade cycle is under way, and with the pandemic propelling digital change like never before, this strong demand phase for devices and tech infrastructure has no end in sight. Companies that cater to this market indicated as much during earnings season.
Three such companies that look like great buys — for the rest of 2021 and for the decade ahead — are Applied Materials (NASDAQ: AMAT), Arista Networks (NYSE: ANET), and Nvidia (NASDAQ: NVDA).
4 September, 2021 by The TZ Newswire Staff Comments Off on Is C3.ai Stock a Buy?
Is C3.ai Stock a Buy?
C3.ai‘s (NYSE: AI) stock tumbled 10% on Sept. 2 after the artificial intelligence software provider posted its first-quarter earnings. Its revenue rose 29% year-over-year to $52.4 million, beating estimates by $1.1 million. It posted a net loss of $37.5 million — compared to a slim profit of $150,000 a year ago — but its loss of $0.37 per share still matched Wall Street’s expectations.
Should investors buy C3 after its post-earnings plunge? Or is it still overvalued even after plummeting more than 70% from its 52-week high?
4 September, 2021 by The TZ Newswire Staff Comments Off on Is C3.ai Stock a Buy?
Is C3.ai Stock a Buy?
C3.ai‘s (NYSE: AI) stock tumbled 10% on Sept. 2 after the artificial intelligence software provider posted its first-quarter earnings. Its revenue rose 29% year-over-year to $52.4 million, beating estimates by $1.1 million. It posted a net loss of $37.5 million — compared to a slim profit of $150,000 a year ago — but its loss of $0.37 per share still matched Wall Street’s expectations.
Should investors buy C3 after its post-earnings plunge? Or is it still overvalued even after plummeting more than 70% from its 52-week high?
4 September, 2021 by The TZ Newswire Staff Comments Off on Chinese Funds Trounce Wall Street Pay, Offer $300,000 To Graduates
Chinese Funds Trounce Wall Street Pay, Offer $300,000 To Graduates
Chinese Funds Trounce Wall Street Pay, Offer $300,000 To Graduates
With bank after bank rushing to hike its entry-level wages to incoming analysts and associates, Wall Street suddenly finds itself facing a much more aggressive competitor: China.
4 September, 2021 by The TZ Newswire Staff Comments Off on Sept. 5 Options Trader Webinar
Sept. 5 Options Trader Webinar
